MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0001769
Elan Pharma (India) Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹72.61 Cr
▲ 12% YoY
Net profit · FY 2025
₹18.31 Cr
Net margin 25.2%
EBITDA · FY 2025
₹25.05 Cr
EBITDA margin 34.5%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹9.43 Lakh
Issued & subscribed
Satisfied charges
₹4.93 Cr
No open charges
Company age
29 yrs
Est. 1997
Employees · EPFO
321
Provident fund records
About Elan Pharma (India) Private Limited
Data last updated:
Elan Pharma (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 June 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1997PTC108497. Its GSTIN is 27AAACE2436M1ZL (Maharashtra). The company holds 8 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹9.43 Lakh. It is led by directors including Dandu Vijay Prakash Raju (Managing Director) and Vidyadhar Dadu Sawant (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 501 – Raikar Chambers Govandi Deonar, Mumbai, Maharashtra, India – 400088.
As per the financials filed for FY 2025, the company reported a revenue of ₹72.61 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹18.31 Cr (net margin 25.2%) and EBITDA of ₹25.05 Cr (EBITDA margin 34.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.
The company has about 321 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹4.93 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending.
Elan Pharma (India) Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0001769). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elanpharma.in.
Company details
CIN U24230MH1997PTC108497
Registration Number 108497
Incorporation Date 04 June 1997
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0001769
Key People
Dandu Vijay Prakash Raju Managing Director Vidyadhar Dadu Sawant Whole-Time Director Aditya Dandu Raju Additional Director Recognitions & Rankings of Elan Pharma (India)
Contact details
Elan Pharma (India) Private Limited's registered office is in Mumbai, Maharashtra. Its website is elanpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address501 – Raikar Chambers Govandi Deonar, Mumbai, Maharashtra, India – 400088
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Elan Pharma (India) Private Limited, buy the company report.
Comprehensive company report
Elan Pharma (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Elan Pharma (India) are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elan Pharma (India) Private Limited, buy the company report.
Financials of Elan Pharma (India) Private Limited
FY 2025 filings availableElan Pharma (India) Private Limited reported revenue of ₹72.61 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹72.61 Cr ▲ 12%
Net profit · FY 2025
₹18.31 Cr margin 25.2%
EBITDA · FY 2025
₹25.05 Cr margin 34.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 10%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 6%
5 years · compounded
▲ 8%
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 12% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.05 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.31 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 34.5% | ||||
| Net Profit Margin | 25.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elan Pharma (India) Private Limited, buy the company report.
Board of directors of Elan Pharma (India) Private Limited
Elan Pharma (India) has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dandu Vijay Prakash Raju | Managing Director | 04 Jun 1997 | 29 Years 4 Months | Current |
| Vidyadhar Dadu Sawant | Whole-Time Director | 07 Sep 2013 | 13 Years 1 Months | Current |
| Aditya Dandu Raju | Additional Director | 28 Jan 2026 | 0 Years 9 Months | Current |
Peer comparison
Elan Pharma (India) Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avn Ayurveda Formulations Private Limited | ₹72.9 Cr (FY 2025) | 6.0% | Madurai, Tamil Nadu, India | |||
| Eskay Herbal Formulations Private Limited | ₹72.88 Cr (FY 2025) | -3.0% | Jalgaon, Maharashtra, India | |||
| Srikar Laboratories Private Limited | ₹72.62 Cr (FY 2025) | -10.0% | Hyderabad, Telangana, India | |||
| Elan Pharma (India) Private Limitedthis company | ₹72.61 Cr (FY 2025) | ₹18.31 Cr | 25.2% | 12.0% | 321 | Mumbai, Maharashtra, India |
| Vance and Health Pharmaceuticals Private Limited | ₹72.08 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Walpar Nutritions Limited | ₹72.03 Cr (FY 2025) | 15.0% | Gandhinagar, Gujarat, India |
To see the full peer comparison of Elan Pharma (India) Private Limited, buy the company report.
Auditor
Elan Pharma (India) Private Limited is audited by Kuldip Mehta & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kuldip Mehta & Co. | FY 2023 | 105400W |
Shareholding
The shareholding of Elan Pharma (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elan Pharma (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹4.93 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2006 | 10016391 | Canara Bank | ₹1.79 Cr | Satisfied | |
| 04 Feb 2003 | 90144306 | Canara Bank | ₹3.75 Lakh | Satisfied | |
| 05 Sep 2001 | 90143556 | Canara Bank | ₹2.8 Cr | Satisfied | |
| 05 Sep 2001 | 90146216 | Canara Bank | ₹15 Lakh | Satisfied | |
| 02 Nov 1999 | 90142600 | Canara Bank | ₹5.47 Lakh | Satisfied |
To see the full charge records of Elan Pharma (India) Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Elan Pharma (India) Private Limited has 3 court cases on record: 2 filed by Elan Pharma (India), 1 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Ors. | Pending |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed against the company by Union of India Secretary Department of Health, A Wing, Nirman Bhavan, , District: New Delhi , , Delhi and 15 others | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Union of India and Anr | Disposed |
To see the full case history of Elan Pharma (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Elan Pharma (India) Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Prashuma Art Printers |
To see the full MSME payment records of Elan Pharma (India) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Elan Pharma (India) Private Limited has a workforce of 321 employees on its EPFO records as of Mar 23, 2024, across 1 active EPFO establishment.
Employee count
321
Active EPFO establishments
1
Employee growth
5.59%
GST
Elan Pharma (India) has 8 GST registrations: 8 active. The first 4 active GSTINs are listed below.
Total GSTINs
8
Active
8
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACE2436M1ZL | Maharashtra | Active | 01 Jul 2017 |
| 27AAACE2436M2ZK | Maharashtra | Active | 01 Apr 2025 |
| 06AAACE2436M1ZP | Haryana | Active | 01 Jul 2017 |
| 08AAACE2436M1ZL | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Elan Pharma (India) Private Limited, buy the company report.
Recent activity
Elan Pharma (India) Private Limited has 7 board changes on record since 1997: 3 appointments and 4 cessations. The latest: Aditya Dandu Raju was appointed as Additional Director on 28 Jan 2026.
Appointed
Aditya Dandu Raju was appointed as Additional Director.
AGM
Elan Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elan Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge registered on 05 Sep 2001 via Charge ID 90143556 with Canara Bank was fully satisfied on 18 Nov 2020.
Ceased
Narendra Kumar Jaiprakash Mittal ceased to be Director.
Charges
A charge registered on 28 Mar 2006 via Charge ID 10016391 with Canara Bank was fully satisfied on 30 May 2018.
Charges
A charge registered on 04 Feb 2003 via Charge ID 90144306 with Canara Bank was fully satisfied on 30 May 2018.
Charges
A charge registered on 05 Sep 2001 via Charge ID 90146216 with Canara Bank was fully satisfied on 30 May 2018.
Charges
A charge registered on 02 Nov 1999 via Charge ID 90142600 with Canara Bank was fully satisfied on 30 May 2018.
Charges
A charge registered on 15 Jul 1997 via Charge ID 90141998 with Canara Bank was fully satisfied on 30 May 2018.
Charges
A charge registered on 15 Jul 1997 via Charge ID 90145901 with Canara Bank was fully satisfied on 30 May 2018.
Ceased
Joseph Peter Sequeira ceased to be Whole-Time Director.
16 earlier events are in the company report.
Frequently asked questions
Elan Pharma (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 June 1997 (29+ years old) and is registered under CIN U24230MH1997PTC108497.
Elan Pharma (India) has 3 current directors:
- Dandu Vijay Prakash Raju - Managing Director
- Vidyadhar Dadu Sawant - Whole-Time Director
- Aditya Dandu Raju - Additional Director
The latest financial statements of Elan Pharma (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Elan Pharma (India) is 27AAACE2436M1ZL, registered in Maharashtra. The company has 8 GST registrations in all, of which 8 are active. Other active GSTINs include 27AAACE2436M2ZK (Maharashtra), 06AAACE2436M1ZP (Haryana), 08AAACE2436M1ZL (Rajasthan).
The CIN (Corporate Identification Number) of Elan Pharma (India) is U24230MH1997PTC108497. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elan Pharma (India) has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Elan Pharma (India) was incorporated on 04 June 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Elan Pharma (India) by revenue are Avn Ayurveda Formulations Private Limited, Eskay Herbal Formulations Private Limited, Srikar Laboratories Private Limited, Vance and Health Pharmaceuticals Private Limited, Walpar Nutritions Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Aditya Dandu Raju was appointed as Additional Director on 28 Jan 2026. Narendra Kumar Jaiprakash Mittal ceased to be Director on 07 Jul 2018. Joseph Peter Sequeira ceased to be Whole-Time Director on 01 Nov 2015. Elan Pharma (India) has 7 board changes on record in total.
Yes, Elan Pharma (India) is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0001769).
Elan Pharma (India) has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 30 Apr 2024.
Elan Pharma (India) can be reached through the website elanpharma.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages